Clinical Trial Update: MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of haploidentical NK cells with SQ IL-15 in adults with relapsed or refractory acute myeloid leukemia has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Haplo NK
• SQ IL-15

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Acute Myelogenous Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-01-10